The Africa Gazette
SEE OTHER BRANDS

The latest news from Africa

The Africa Gazette: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Africa Gazette.

Press releases published on May 16, 2025

STUDIO SALE OF AFRICAN AMERICAN ARTIST VINCENT SMITH

STUDIO SALE OF AFRICAN AMERICAN ARTIST VINCENT SMITH

May 27th at 12pm EST. LARCHMONT, NY, UNITED STATES, May 16, 2025 /⁨EINPresswire.com⁩/ -- Vincent D. Smith (1929 - 2003) is distinctive for his adept utilization of mixed media, striking colors, and references to the rich visual culture of the African …

GoldHaven Clarifies Technical Disclosure

GoldHaven Clarifies Technical Disclosure

VANCOUVER, British Columbia, May 16, 2025 (GLOBE NEWSWIRE) -- GoldHaven Resources Corp. (CSE: GOH) (“GoldHaven” or the “Company”) announces that, based upon a review of the Company’s disclosure by the British Columbia Securities Commission (“BCSC”), it …

Aventis Energy Inc. Announces Marketing Program

Aventis Energy Inc. Announces Marketing Program

VANCOUVER, British Columbia, May 16, 2025 (GLOBE NEWSWIRE) -- Aventis Energy. (“Aventis” or the “Company”) (CSE: AVE | OTC: VBAMF), is pleased to announce that it entered into an agreement (the “Agreement”) with RMK Marketing Inc. (“RMK”) on May 16, 2025, …

HPQ Silicon Reinstated for Trading

HPQ Silicon Reinstated for Trading

MONTREAL, May 16, 2025 (GLOBE NEWSWIRE) -- HPQ Silicon Inc. (“HPQ” or the “Company”) (TSX-V: HPQ, OTCQB: HPQFF, FRA: O08), a technology company developing next-generation processes for advanced material manufacturing, announces that on May 15, 2025, the …

HPQ Silicium : Réadmission a la cote des titres

HPQ Silicium : Réadmission a la cote des titres

MONTRÉAL, 16 mai 2025 (GLOBE NEWSWIRE) -- HPQ Silicium inc. (« HPQ » ou « la Société ») (TSX-V: HPQ, OTCQB: HPQFF, FRA: O08), entreprise technologique spécialisée dans le développement de nouveaux procédés industriels annonce que, le 15 mai 2025, la Bourse …

Silo Pharma Announces Closing of $2 Million Public Offering

Silo Pharma Announces Closing of $2 Million Public Offering

SARASOTA, FL, May 16, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical company focused on novel therapeutics and drug delivery systems, closed on the previously announced public …

Azimut Closes $8.7 Million Private Placement

Azimut Closes $8.7 Million Private Placement

LONGUEUIL, Québec, May 16, 2025 (GLOBE NEWSWIRE) -- Azimut Exploration Inc. (“Azimut” or the “Company”) (TSXV: AZM) (OTCQX: AZMTF) is pleased to report that on May 16, 2025, it has closed its previously announced non-brokered placement with Centerra Gold …

Azimut clôture un placement privé de 8,7 millions $

Azimut clôture un placement privé de 8,7 millions $

LONGUEUIL, Québec, 16 mai 2025 (GLOBE NEWSWIRE) -- Exploration Azimut Inc. (« Azimut » ou la « Société ») (TSXV : AZM) (OTCQX : AZMTF) a le plaisir d’annoncer que le 16 mai 2025, elle a clôturé le placement privé sans intermédiaire précédemment annoncé …

US Inflation Slows, USD Faces Turning Point: EBC Financial Group on What Traders Should Watch Next

US Inflation Slows, USD Faces Turning Point: EBC Financial Group on What Traders Should Watch Next

With CPI at a 4-year low, EBC Financial Group highlights how shifting rate bets and USD swings open new chances for currency, CFD, and gold traders. DC, UNITED STATES, May 16, 2025 /⁨EINPresswire.com⁩/ -- April’s U.S. Consumer Price Index (CPI) came in at …

Bessor Announces $125,000 Private Placement Financing and Provides Corporate Update

Bessor Announces $125,000 Private Placement Financing and Provides Corporate Update

Vancouver, BC, May 16, 2025 (GLOBE NEWSWIRE) -- Bessor Minerals Inc. (TSXV:BST) ("Bessor" or the “Corporation”) is pleased to announce that it intends to complete a non-brokered private placement offering of up to 6,250,000 common shares in the capital of …

BlueSphere Bio Appoints Alan Korman, Ph.D. as Chief Scientific Officer

BlueSphere Bio Appoints Alan Korman, Ph.D. as Chief Scientific Officer

PITTSBURGH, May 16, 2025 (GLOBE NEWSWIRE) -- BlueSphere Bio, a clinical stage drug development company focused on novel T cell based therapies, today announced the appointment of Alan Korman, Ph.D., as Chief Scientific Officer. Dr. Korman brings extensive …

Medicines for Poland: Europa steht vor einer kritischen Entscheidung über Arzneimittel und Marktreformen

Medicines for Poland: Europa steht vor einer kritischen Entscheidung über Arzneimittel und Marktreformen

Warschau, Polen, May 16, 2025 (GLOBE NEWSWIRE) -- Die Mitgliedstaaten stehen kurz vor dem Abschluss der Diskussionen über die EU-Arzneimittelreform, mit der erschwingliche Medikamente sichergestellt und die Produktion in Europa gefördert werden sollen. …

Medicines for Poland : l’Europe fait face à un dilemme majeur sur la question des médicaments et de la réforme du marché

Medicines for Poland : l’Europe fait face à un dilemme majeur sur la question des médicaments et de la réforme du marché

VARSOVIE, Pologne, 16 mai 2025 (GLOBE NEWSWIRE) -- Les États membres s’apprêtent à conclure les discussions sur la réforme pharmaceutique de l’UE afin de garantir des médicaments abordables et de soutenir la production de l’UE au sein de l’Europe. Cela …

Medicines for Poland : l'Europe face à un choix crucial en matière de médicaments et de réforme du marché

Medicines for Poland : l'Europe face à un choix crucial en matière de médicaments et de réforme du marché

VARSOVIE, Pologne, 16 mai 2025 (GLOBE NEWSWIRE) -- Les États membres approchent de la fin des discussions sur la réforme pharmaceutique de l'UE visant à garantir des médicaments abordables et à soutenir la fabrication de médicaments de l'UE en Europe. Cela …

GRI Bio to Present at A.G.P.'s Annual Healthcare Company Showcase

GRI Bio to Present at A.G.P.'s Annual Healthcare Company Showcase

Live webcast fireside chat with Marc Hertz, PhD, Chief Executive Officer on Wednesday, May 21st at 2:40 PM ET LA JOLLA, CA, May 16, 2025 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an …

BON Announces The Launch Of Its Postbiotic Hypoglycemic Patented Ingredient Product Series And Its Cooperation Agreement

BON Announces The Launch Of Its Postbiotic Hypoglycemic Patented Ingredient Product Series And Its Cooperation Agreement

XI’AN, China, May 16, 2025 (GLOBE NEWSWIRE) -- Bon Natural Life Limited (Nasdaq: BON) ("BON" or the "Company"), a leading bio-ingredient solution provider in the natural, health and personal care industry, announced an exclusive cooperation agreement with …

Medicines for Poland: Europe Faces a Critical Choice on Medicines and Market Reform

Medicines for Poland: Europe Faces a Critical Choice on Medicines and Market Reform

WARSAW, Poland, May 16, 2025 (GLOBE NEWSWIRE) -- Member States are nearing the end of discussions on EU pharmaceutical reform to ensure affordable medicines and support EU manufacturing in Europe. This will enhance the Union’s strategic resilience and …

Rio Silver Receives Conditional Approval for Acquisition of Mamaniña Exploraciones S.A.C.

Rio Silver Receives Conditional Approval for Acquisition of Mamaniña Exploraciones S.A.C.

VANCOUVER, British Columbia, May 16, 2025 (GLOBE NEWSWIRE) -- Rio Silver Inc. (the “Company”) (TSX.V: RYO) (OTC: RYOOF) announces that, further to its announcement on March 26, 2025, it has received from the TSX Venture Exchange (the “Exchange”) …

Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SOUTH SAN FRANCISCO, Calif., May 16, 2025 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”, “Company”), a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for liver and …

Vivex Biologics, Inc. Executive Chair Nominated for Ernst & Young LLP Entrepreneur of the Year® 2025 Florida Award

Vivex Biologics, Inc. Executive Chair Nominated for Ernst & Young LLP Entrepreneur of the Year® 2025 Florida Award

MIAMI, May 16, 2025 (GLOBE NEWSWIRE) -- Vivex Biologics, Inc., a leader in developing and delivering innovative allografts, today announced the company’s Executive Chairman, John A. McCallum, has been selected as a finalist in the prestigious Ernst …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service